- OMXSPI 0.97% 795.37
- FN25 1.29% 2239.33
- OMXS30 0.83% 2155.49
Double Bond Pharmaceutical B
Spotlight Stock Market
0.54
0.04 8.4 %
Stock information
- Company Double Bond Pharmaceutical B
- Currency SEK
- Turnover 154 352 SEK
- % 8.4
- + / - 0.04
- Buy -
- Sell -
- High 2
- Low -
- Last updated 2023-09-29 17:29
Company information
Double Bond Pharmaceutical, DBP, is a pharmaceutical company. The main focus is on the treatment of severe forms of cancer, infections and autoimmune diseases. The research is based on the company's proprietary technology. The products are sold under separate trademarks and collaboration on product development is done together with other players in the field. The company is based in Uppsala.
- Number of shares 95 Millions
- Stock market value 52 MSEK
- Average daily turnover 685 TSEK
- CEO Igor Lokot
- Chairman of the Board Sanna Rejnlander
- Volatility 30 days 196.70%
- Volatility 200 days 166.25%
- Dividend -
- Latest annual report -
- Absolute return -
Owners
| Name | Ownership | Last modified |
|---|---|---|
| Igor Lokot | 10.1% | 2023-06-30 |
| KSDR Hamberg AB | 7.7% | 2023-06-30 |
| Per Ahlström | 7.3% | 2023-06-30 |
| Investentia AB | 5.2% | 2023-06-30 |
| Formue Nord A/S | 3.7% | 2023-06-30 |
| Avanza Pension | 3.1% | 2023-06-30 |
| QQM Fund Management AB | 3.1% | 2023-06-30 |
| Carl Carvalho | 2.5% | 2023-06-30 |
| Magnus Hamberg | 2.5% | 2023-06-30 |
| Thomas Trumstedt | 1.8% | 2023-06-30 |